您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Alexa Fluor® 488 Rat Anti-Mouse CD86/B7-2 Antibody (S-R434)

Alexa Fluor® 488 Rat Anti-Mouse CD86/B7-2 Antibody (S-R434)

货号: S0B1673
价格: 2265
规格: 100T
介绍: -
其他: -
产品规格
  • 宿主来源

    Rat
  • 抗原名称

    CD86/B7-2
  • 分子别名

    T-lymphocyte activation antigen CD86; Activation B7-2 antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1
  • 细胞定位

    Cell membrane
  • Accession

    P42081
  • 克隆号

    S-R434
  • 抗体类型

    Rat mAb
  • 抗体同种型

    IgG2a,k
  • 应用

    FCM
  • 反应种属 ?

    Ms
  • 阳性样本

    C57BL/6 mouse splenocytes treated with LPS
  • 纯化方式

    Protein G
  • 浓度

    0.2 mg/ml
  • 标记

    Alexa Fluor® 488
  • 性状

    Liquid
  • 缓冲体系

    PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

稀释度
应用 稀释度 推荐种属
FCM 5 μl per million cells in 100μl volume Ms
背景介绍
  • CD86, also known as B7-2, is a crucial protein molecule in the immune system, belonging to the B7 protein family. This family comprises various costimulatory molecules that are essential for T-cell activation, proliferation, and the exertion of effector functions. CD86 provides the second signal (costimulatory signal) for T-cell activation by binding to the CD28 receptor on T-cells. This signal is necessary for the full activation and differentiation of T-cells into effector T-cells (e.g., Th1, Th2) or memory T-cells. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses.